お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
987779

臨床化学分析装置の世界市場:製品別 (全自動分析装置、PoC分析装置、試薬)・検査の種類別 (基礎代謝、肝臓、腎臓、脂質、甲状腺機能)・エンドユーザー別 (病院・診療所、検査室、研究機関) の将来予測 (2026年まで)

Clinical Chemistry Analyzers Market by Product (Fully-Automated Analyzers, PoC Analyzers, Reagents), Test Type (Basic Metabolic, Liver, Renal, Lipid, Thyroid Function), End User (Hospitals, Clinics, Laboratories, Research) - Global Forecast to 2026

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 151 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=109.37円
臨床化学分析装置の世界市場:製品別 (全自動分析装置、PoC分析装置、試薬)・検査の種類別 (基礎代謝、肝臓、腎臓、脂質、甲状腺機能)・エンドユーザー別 (病院・診療所、検査室、研究機関) の将来予測 (2026年まで)
出版日: 2021年02月08日
発行: MarketsandMarkets
ページ情報: 英文 151 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の臨床化学分析装置の市場規模は、2021年の123億米ドルから、2026年には152億米ドルに達すると予測されており、予測期間中のCAGRは4.3%と推計されています。市場の主な促進要因として、高齢者人口の増加や、慢性疾患・生活習慣病の有病率の上昇、PoC (ポイントオブケア) 検査装置の普及、ラボラトリーオートメーションの需要増大などが挙げられます。一方、多額の設備投資や臨床検査技術者の不足、中古品の入手可能性といった要素が、市場成長の妨げとなる可能性もあります。

製品別では試薬の市場規模が、検査の種類別では脂質プロファイル向け需要が、今後大きく成長すると見込まれています。エンドユーザー別では病院・診療所向け需要が最も成長率が高く、地域別ではアジア太平洋諸国 (中国・日本など) での急速な市場成長が期待されています。

当レポートでは、世界の臨床化学分析装置の市場について分析し、市場の基本構造や最新情勢、主な市場促進・阻害要因、市場動向の見通し (今後6年間分)、製品別・検査の種類別・エンドユーザー別・地域別の詳細動向、市場競争の状態、主要企業のプロファイルなどを調査しております。

目次

第1章 イントロダクション

第2章 分析方法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概略

  • イントロダクション
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 市場機会
    • 市場動向
    • 新型コロナウイルス感染症 (COVID-19) の影響分析
  • 価格分析
  • バリューチェーン分析
  • サプライチェーン分析
  • エコシステム分析
  • ポーターのファイブフォース分析
  • PESTLE分析

第6章 臨床化学分析装置の市場:製品別

  • イントロダクション
  • 試薬
  • 分析装置
    • 半自動分析装置
    • 全自動分析装置
    • PoC (ポイントオブケア) 分析装置
  • その他の製品

第7章 臨床化学分析装置の市場:検査の種類別

  • イントロダクション
  • BMP (基礎代謝パネル)
  • 肝臓パネル
  • 腎臓プロファイル
  • 脂質プロファイル
  • 甲状腺機能パネル
  • 電解質パネル
  • 特殊化学検査

第8章 臨床化学分析装置の市場:エンドユーザー別

  • イントロダクション
  • 病院・診療所
  • 診断検査室
  • 研究機関
  • その他のエンドユーザー

第9章 臨床化学分析装置の市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ロシア
    • 他の欧州諸国
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 他のアジア太平洋諸国
  • ラテンアメリカ
  • 中東・アフリカ

第10章 競合情勢

  • 概要
  • 市場シェア分析
  • 企業戦略の方向性:マッピング
    • 分析対象ベンダーの一覧
    • 先駆的企業
    • 革新的企業
    • 活動的企業
    • 新規企業
  • 企業戦略の方向性:マッピング (スタートアップ企業の場合)
    • 進歩的企業
    • 新規参入企業
    • 追従的企業
    • 活動的企業
  • 競合シナリオ
    • 新製品の発売
    • 企業買収
    • 事業提携・協力、契約
    • 事業拡張

第11章 企業プロファイル

  • (事業概要、主要製品・サービス、近年の動向、MnMの見解)
  • ROCHE DIAGNOSTICS LTD.
  • DANAHER CORPORATION
  • ABBOTT LABORATORIES
  • THERMO FISHER SCIENTIFIC INC.
  • SIEMENS HEALTHINEERS AG
  • HORIBA, LTD.
  • SYSMEX CORPORATION
  • EKF DIAGNOSTICS
  • HITACHI
  • ORTHO CLINICAL DIAGNOSTICS
  • ELITECHGROUP
  • MINDRAY MEDICAL INTERNATIONAL LTD.
  • BIOBASE GROUP
  • SFRI MEDICAL DIAGNOSTICS
  • TRIVITRON HEALTHCARE PVT. LTD.
  • RANDOX LABORATORIES LTD.
  • MEDICA CORPORATION
  • MERIL LIFE SCIENCES PVT. LTD.
  • ERBA MANNHEIM
  • GENRUI BIOTECH INC.
  • DIRUI INDUSTRIAL CO., LTD.
  • TECO DIAGNOSTICS
  • BALIO DIAGNOSTICS
  • SNIBE CO. LTD.
  • AMS ALLIANCE

第12章 付録

目次
Product Code: MD 2843

The global clinical chemistry analyzers market size is projected to reach USD 15.2 billion by 2026 from USD 12.3 billion in 2021, at a CAGR of 4.3% during the forecast period. Market growth is driven by factors such as the rising geriatric population and the increasing prevalence of chronic & lifestyle diseases, growing adoption of Point-of-Care testing devices and rising demand for laboratory automation. On the other hand, high capital investment, shortage of clinical laboratory technicians, and the availability of refurbished products is expected to limit market growth to a certain extent in the coming years.

"The reagents accounted for the highest growth rate in the clinical chemistry analyzers market, by product, during the forecast period"

The clinical chemistry analyzers market is segmented into analyzers, reagents and other products. The reagents segment accounted for the highest growth rate in the clinical chemistry analyzers market in 2020. The requirement reagents in large numbers compared to analyzers is the main factor contributing to this segment's high growth rate. This segment's market growth can also be attributed to repeat purchases of reagents compared to analyzers.

"Lipid profile tests segment accounted for the highest CAGR"

Based on the test type, the clinical chemistry analyzers market is segmented basic metabolic panels, electrolyte panels, liver panels, lipid profiles, renal profiles, thyroid function panels, and specialty chemical tests. In 2020, the lipid profile tests segment accounted for the highest growth rate. Rapid growth in obesity rates and the increasing incidence of obesity-related diseases are the major factors driving this segment's growth.

"Hospitals and clinics segment accounted for the highest CAGR"

Based on end-users, the clinical chemistry analyzers market is segmented into hospitals and clinics, diagnostic laboratories, research laboratories & institutes, and other end users. In 2020, the hospitals and clinics segment accounted for the highest growth rate. This can be attributed to increasing number of hospitals worldwide owing to the increasing incidences of diseases & disorders, increasing adoption of analyzers and rising technological advancements.

"Asia Pacific: The fastest-growing region clinical chemistry analyzers market"

The global clinical chemistry analyzers market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Growth in this region is expected to be centered on China and Japan. Factors such as the rising geriatric population, high burden of chronic diseases, growing per capita income, increasing investments in the healthcare industry by key market players, rising demand for cutting-edge technologies, expansion of private-sector hospitals to rural areas in various APAC countries, an increasing number of hospitals and clinicsare driving the growth of the clinical chemistry analyzers market in this region.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 20%, Tier 2 - 45%, and Tier 3 - 35%
  • By Designation: C-level - 30%, D-level - 20%, and Others - 50%
  • By Region: North America - 36%, Europe - 25%, Asia Pacific - 27%, Latin America - 9% , and the Middle East & Africa - 3%

Lits of Companies Profiled in the Report:

  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Danaher Corporation (US)
  • Abbott Laboratories (US)
  • Thermo Fisher Scientific Inc. (US)
  • Siemens AG (Germany)
  • HORIBA Ltd. (Japan)
  • Sysmex Corporation (Japan)
  • HITACHI (Japan)
  • EKF Diagnostics (UK)
  • Ortho Clinical Diagnostics (US)
  • ELITech Group (France)
  • Mindray Medical International Ltd. (China)
  • BIOBASE Group (China)
  • SFRI Medical Diagnostics (France)
  • Trivitron Healthcare Pvt. Ltd. (India)
  • Randox Laboratories Ltd. (UK)
  • Medica Corporation (US)
  • Meril Life Sciences Pvt. Ltd. (India)
  • Erba Mannheim (UK)
  • Genrui Biotech Inc. (China)
  • DIRUI Industrial Co. Ltd. (China)
  • Teco Diagnostics (US)
  • Balio Diagnostics (France)
  • Snibe Co. Ltd. (China)
  • AMS Alliance (Italy)

Research Coverage:

This report provides a detailed picture of the global clinical chemistry analyzers market. It aims at estimating the size and future growth potential of the market across different segments, such as product, test type, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall clinical chemistry analyzers market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • FIGURE 1 INCLUSIONS & EXCLUSIONS
    • 1.2.1 MARKETS COVERED
    • FIGURE 2 CLINICAL CHEMISTRY ANALYZERS MARKET
    • 1.2.2 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH APPROACH
    • FIGURE 3 CLINICAL CHEMISTRY ANALYZERS MARKET: RESEARCH DESIGN METHODOLOGY
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
      • 2.2.2.1 Key data from primary sources
  • 2.3 MARKET SIZE ESTIMATION
    • 2.3.1 BOTTOM-UP APPROACH
    • FIGURE 5 CLINICAL CHEMISTRY ANALYZERS MARKET: BOTTOM-UP APPROACH
    • 2.3.2 TOP-DOWN APPROACH
    • FIGURE 6 CLINICAL CHEMISTRY ANALYZER MARKET: TOP-DOWN APPROACH
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • 2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

    • FIGURE 8 CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
    • FIGURE 9 CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 10 CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 11 CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    • FIGURE 12 CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)

4 PREMIUM INSIGHTS

  • 4.1 CLINICAL CHEMISTRY ANALYZERS MARKET OVERVIEW
    • FIGURE 13 THE RISING ADOPTION OF POC PRODUCTS IS EXPECTED TO SUPPORT MARKET GROWTH DURING THE FORECAST PERIOD
  • 4.2 CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
    • FIGURE 14 THE REAGENTS SEGMENT IS EXPECTED TO COMMAND THE LARGEST SHARE OF THE MARKET, BY PRODUCT, IN 2021
  • 4.3 CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 15 THE SEMI-AUTOMATIC ANALYZER SEGMENT IS EXPECTED TO HOLD THE LARGEST SHARE OF THE MARKET, BY TYPE, DURING THE FORECAST PERIOD
  • 4.4 CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION, 2021 VS. 2026
    • FIGURE 16 THE ASIA PACIFIC MARKET IS ESTIMATED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 17 CLINICAL CHEMISTRY ANALYZER MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND TRENDS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising geriatric population and the increasing prevalence of chronic & lifestyle diseases
    • TABLE 1 ESTIMATED INCREASE IN THE GERIATRIC POPULATION, BY REGION (2019-2050)
      • 5.2.1.2 Growing adoption of Point-of-Care testing devices
      • 5.2.1.3 Increasing demand for laboratory automation
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 The requirement of high capital investments and a shortage of skilled laboratory technicians
      • 5.2.2.2 Availability of refurbished analyzers
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Increasing government initiatives and funding for preventive care
    • 5.2.4 TRENDS
      • 5.2.4.1 Multichannel operations of integrated analyzers
    • 5.2.5 COVID 19 IMPACT ANALYSIS
  • 5.3 PRICING ANALYSIS
    • TABLE 2 AVERAGE SELLING PRICES OF PRODUCTS (USD)
  • 5.4 VALUE CHAIN ANALYSIS
    • FIGURE 18 VALUE CHAIN ANALYSIS OF THE CLINICAL CHEMISTRY ANALYZERS MARKET
  • 5.5 SUPPLY CHAIN ANALYSIS
    • FIGURE 19 SUPPLY CHAIN ANALYSIS
  • 5.6 ECOSYSTEM ANALYSIS
  • 5.7 PORTER'S FIVE FORCES ANALYSIS
    • FIGURE 20 PORTER'S FIVE FORCES ANALYSIS
    • 5.7.1 THREAT FROM NEW ENTRANTS
    • 5.7.2 THREAT FROM SUBSTITUTES
    • 5.7.3 BARGAINING POWER OF BUYERS
    • 5.7.4 BARGAINING POWER OF SUPPLIERS
    • 5.7.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
  • 5.8 PESTLE ANALYSIS

6 CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 3 CLINICAL CHEMISTRY REAGENTS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
  • 6.2 REAGENTS
    • 6.2.1 THE RECURRENT PURCHASE REQUIREMENT OF REAGENTS DRIVES MARKET GROWTH
    • TABLE 4 CLINICAL CHEMISTRY REAGENTS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 6.3 ANALYZERS
    • TABLE 5 CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 6 CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.1 SEMI-AUTOMATIC ANALYZERS
      • 6.3.1.1 The cost-effectiveness of semi-automatic analyzers drives segment growth
    • TABLE 7 SEMI-AUTOMATIC ANALYZERS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.2 FULLY AUTOMATIC ANALYZERS
      • 6.3.2.1 Fully automatic analyzers offer rapid sample processing, thus enhancing workflows
    • TABLE 8 FULLY AUTOMATIC ANALYZERS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.3 POINT-OF-CARE ANALYZERS
      • 6.3.3.1 The increasing adoption of PoC technologies drives segment growth
    • TABLE 9 POINT-OF-CARE ANALYZERS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 6.4 OTHER PRODUCTS
    • TABLE 10 CLINICAL CHEMISTRY ANALYZERS FOR OTHER PRODUCTS MARKET, BY REGION, 2019-2026 (USD MILLION)

7 CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE

  • 7.1 INTRODUCTION
    • TABLE 11 CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
  • 7.2 BASIC METABOLIC PANEL
    • 7.2.1 THE RISING INCIDENCE OF DIABETES AND OTHER CHRONIC DISEASES IS A PRIMARY GROWTH DRIVER FOR THIS SEGMENT
    • TABLE 12 BASIC METABOLIC PANEL TESTS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 7.3 LIVER PANEL
    • 7.3.1 THE INCREASING INCIDENCE OF LIVER-RELATED DISEASES IS A KEY FACTOR DRIVING MARKET GROWTH
    • TABLE 13 LIVER PANEL TESTS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 7.4 RENAL PROFILE
    • 7.4.1 THE RISING INCIDENCE OF ESRD PATIENTS DRIVES THE GROWTH OF THE RENAL PROFILE TESTING MARKET
    • TABLE 14 RENAL PROFILE TESTS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 7.5 LIPID PROFILE
    • 7.5.1 LIPID PROFILE TESTS ARE PRESCRIBED TO MONITOR UNHEALTHY LIPID LEVELS AND AVOID CVD RISKS
    • TABLE 15 LIPID PROFILE TESTS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 7.6 THYROID FUNCTION PANEL
    • 7.6.1 THE INCREASING INCIDENCE OF THYROID-RELATED DISORDERS DRIVES THE GROWTH OF THIS SEGMENT
    • TABLE 16 THYROID FUNCTION PANEL TESTS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 7.7 ELECTROLYTE PANEL
    • 7.7.1 THE ELECTROLYTE TEST PANEL IS PRESCRIBED TO PATIENTS THAT SUFFER FROM HYPERTENSION OR LIVER & KIDNEY DISEASES
    • TABLE 17 ELECTROLYTE PANEL TESTS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 7.8 SPECIALTY CHEMICAL TESTS
    • 7.8.1 THIS SEGMENT IS EXPECTED TO GROW AT THE LOWEST CAGR DURING THE FORECAST PERIOD AS THESE TESTS ARE NOT PRESCRIBED REGULARLY
    • TABLE 18 SPECIALTY CHEMICAL TESTS MARKET, BY REGION, 2019-2026 (USD MILLION)

8 CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 19 CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 8.2 HOSPITALS AND CLINICS
    • 8.2.1 HOSPITALS ARE THE MAJOR END USERS OF CLINICAL CHEMISTRY ANALYZERS
    • TABLE 20 CLINICAL CHEMISTRY ANALYZERS MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2019-2026 (USD MILLION)
  • 8.3 DIAGNOSTIC LABORATORIES
    • 8.3.1 INCREASING OUTSOURCING ACTIVITIES TO DIAGNOSTIC LABORATORIES FOR REDUCED COSTS DRIVE THE GROWTH OF THIS SEGMENT
    • TABLE 21 CLINICAL CHEMISTRY ANALYZERS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2019-2026 (USD MILLION)
  • 8.4 RESEARCH LABORATORIES & INSTITUTES
    • 8.4.1 GROWTH IN FUNDING FOR LIFE SCIENCE RESEARCH IS A PRIMARY DRIVER FOR THIS END-USER SEGMENT
    • TABLE 22 CLINICAL CHEMISTRY ANALYZERS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2019-2026 (USD MILLION)
  • 8.5 OTHER END USERS
    • TABLE 23 CLINICAL CHEMISTRY ANALYZERS MARKET FOR OTHER END USERS, BY REGION, 2019-2026 (USD MILLION)

9 CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 24 CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 21 NORTH AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET SNAPSHOT
    • TABLE 25 NORTH AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 26 NORTH AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 27 NORTH AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 28 NORTH AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
    • TABLE 29 NORTH AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 Increasing cases of diabetes & obesity-related diseases is a key factor expected to drive market growth
    • TABLE 30 US: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 31 US: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 32 US: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
    • TABLE 33 US: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 The increasing prevalence of chronic & lifestyle diseases drives the market growth in Canada
    • TABLE 34 CANADA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 35 CANADA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 36 CANADA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
    • TABLE 37 CANADA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 38 EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 39 EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 40 EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 41 EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
    • TABLE 42 EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.1 UK
      • 9.3.1.1 The increasing number of accredited clinical laboratories in the UK propels market growth for chemical analyzers
    • TABLE 43 UK: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 44 UK: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 45 UK: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
    • TABLE 46 UK: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.2 GERMANY
      • 9.3.2.1 Increasing healthcare expenditure to drive market growth in Germany
    • TABLE 47 GERMANY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 48 GERMANY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 49 GERMANY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
    • TABLE 50 GERMANY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.3 FRANCE
      • 9.3.3.1 Rising R&D expenditure in France to drive market growth
    • TABLE 51 FRANCE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 52 FRANCE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 53 FRANCE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
    • TABLE 54 FRANCE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.4 ITALY
      • 9.3.4.1 Age-related chronic conditions owing to a large geriatric population to drive market growth in Italy
    • TABLE 55 ITALY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 56 ITALY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 57 ITALY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
    • TABLE 58 ITALY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.5 SPAIN
      • 9.3.5.1 Increasing prevalence of age-associated disorders to drive market growth in Spain
    • TABLE 59 SPAIN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 60 SPAIN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 61 SPAIN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
    • TABLE 62 SPAIN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.6 RUSSIA
      • 9.3.6.1 Increasing access to quality healthcare will support market growth in Russia
    • TABLE 63 RUSSIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 64 RUSSIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 65 RUSSIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
    • TABLE 66 RUSSIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.7 REST OF EUROPE (ROE)
    • TABLE 67 ROE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 68 ROE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 69 ROE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
    • TABLE 70 ROE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 22 APAC: CLINICAL CHEMISTRY ANALYZERS MARKET SNAPSHOT
    • TABLE 71 APAC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 72 APAC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 73 APAC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 74 APAC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
    • TABLE 75 APAC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.4.1 CHINA
      • 9.4.1.1 China accounted for the largest share of the APAC market in 2020
    • TABLE 76 CHINA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 77 CHINA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 78 CHINA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
    • TABLE 79 CHINA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.4.2 JAPAN
      • 9.4.2.1 A favorable regulatory framework to drive market growth in Japan
    • TABLE 80 JAPAN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 81 JAPAN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 82 JAPAN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
    • TABLE 83 JAPAN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.4.3 INDIA
      • 9.4.3.1 Increasing private & public investments in the country's healthcare system will drive market growth
    • TABLE 84 INDIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 85 INDIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 86 INDIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
    • TABLE 87 INDIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.4.4 REST OF ASIA PACIFIC (ROAPAC)
    • TABLE 88 ROAPAC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 89 ROAPAC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 90 ROAPAC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
    • TABLE 91 ROAPAC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.5 LATIN AMERICA
    • TABLE 92 LATIN AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 93 LATIN AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 94 LATIN AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
    • TABLE 95 LATIN AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.6 MIDDLE EAST AND AFRICA
    • TABLE 96 MEA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 97 MEA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 98 MEA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2019-2026 (USD MILLION)
    • TABLE 99 MEA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2019-2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
    • FIGURE 23 KEY DEVELOPMENTS IN THE CLINICAL CHEMISTRY ANALYZERS MARKET
  • 10.2 MARKET SHARE ANALYSIS
    • FIGURE 24 CLINICAL CHEMISTRY ANALYZERS MARKET SHARE, BY KEY PLAYER (2019)
  • 10.3 COMPANY EVALUATION QUADRANT
    • 10.3.1 LIST OF EVALUATED VENDORS
    • 10.3.2 STARS
    • 10.3.3 EMERGING LEADERS
    • 10.3.4 PERVASIVE PLAYERS
    • 10.3.5 PARTICIPANTS
    • FIGURE 25 CLINICAL CHEMISTRY ANALYZERS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019
  • 10.4 COMPETITIVE EVALUATION MATRIX FOR START-UPS (2019)
    • 10.4.1 PROGRESSIVE COMPANIES
    • 10.4.2 STARTING BLOCKS
    • 10.4.3 RESPONSIVE COMPANIES
    • 10.4.4 DYNAMIC COMPANIES
    • FIGURE 26 CLINICAL CHEMISTRY ANALYZERS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS, 2019
  • 10.5 COMPETITIVE SCENARIO
    • 10.5.1 PRODUCT LAUNCHES
    • TABLE 100 KEY PRODUCT LAUNCHES
    • 10.5.2 ACQUISITIONS
    • TABLE 101 KEY ACQUISITIONS
    • 10.5.3 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
    • TABLE 102 KEY PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
    • 10.5.4 EXPANSIONS
    • TABLE 103 KEY EXPANSIONS

11 COMPANY PROFILES

  • (Business Overview, Products Offered, Recent Developments, and MnM View)**
  • 11.1 ROCHE DIAGNOSTICS LTD.
    • FIGURE 27 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2019)
  • 11.2 DANAHER CORPORATION
    • FIGURE 28 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
  • 11.3 ABBOTT LABORATORIES
    • FIGURE 29 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)
  • 11.4 THERMO FISHER SCIENTIFIC INC.
    • FIGURE 30 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2019)
  • 11.5 SIEMENS HEALTHINEERS AG
    • FIGURE 31 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT
  • 11.6 HORIBA, LTD.
    • FIGURE 32 HORIBA LTD.: COMPANY SNAPSHOT (2019)
  • 11.7 SYSMEX CORPORATION
    • FIGURE 33 SYSMEX CORPORATION: COMPANY SNAPSHOT (2019)
  • 11.8 EKF DIAGNOSTICS
    • FIGURE 34 EKF DIAGNOSTICS: COMPANY SNAPSHOT
  • 11.9 HITACHI
    • FIGURE 35 HITACHI LTD.: COMPANY SNAPSHOT (2019)
  • 11.10 ORTHO CLINICAL DIAGNOSTICS
    • 11.10.1 BUSINESS OVERVIEW
    • 11.10.2 PRODUCTS OFFERED
    • 11.10.3 RECENT DEVELOPMENTS
  • 11.11 ELITECHGROUP
  • 11.12 MINDRAY MEDICAL INTERNATIONAL LTD.
  • 11.13 BIOBASE GROUP
  • 11.14 SFRI MEDICAL DIAGNOSTICS
  • 11.15 TRIVITRON HEALTHCARE PVT. LTD.
  • 11.16 RANDOX LABORATORIES LTD.
  • 11.17 MEDICA CORPORATION
  • 11.18 MERIL LIFE SCIENCES PVT. LTD.
  • 11.19 ERBA MANNHEIM
  • 11.20 GENRUI BIOTECH INC.
  • 11.21 DIRUI INDUSTRIAL CO., LTD.
  • 11.22 TECO DIAGNOSTICS
  • 11.23 BALIO DIAGNOSTICS
  • 11.24 SNIBE CO. LTD.
  • 11.25 AMS ALLIANCE
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 12.2 DISCUSSION GUIDE
  • 12.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4 AVAILABLE CUSTOMIZATIONS
  • 12.5 RELATED REPORTS
  • 12.6 AUTHOR DETAILS
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.